LipoScience pulls in $45 million from public offering

01/30/2013 | Clinica (subscription required)

LipoScience has secured $45 million in a just-completed initial public offering. The Raleigh, N.C.-based in vitro diagnostics company plans to use about $38.6 million in expected net proceeds from the offering in part to fund its research and development projects, including initiatives to increase its Vantera system's test menu.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT